Rna Interference (RNAi) is a natural cellular mechanism that regulates gene expression by silencing specific target genes through the degradation of messenger RNA (mRNA). This process plays a fundamental role in controlling various biological processes, including development, immune response, and defense against viral infections. The discovery of RNAi has paved the way for its application as a powerful tool in molecular biology and therapeutic interventions. Small RNA molecules, such as small interfering RNA (siRNA) and microRNA (miRNA), are key players in RNA interference. Synthetic siRNAs, designed to match the sequence of a target gene, can be introduced into cells to trigger the degradation of the corresponding mRNA, effectively inhibiting gene expression. Similarly, endogenous miRNAs regulate gene expression by binding to target mRNAs, leading to translational repression or mRNA degradation. RNAi technology has become a widely used experimental tool in laboratories, enabling researchers to selectively silence genes of interest to study their function. In the realm of therapeutics, RNAi holds immense potential for treating various diseases, including genetic disorders, viral infections, and certain types of cancer. Efforts are underway to develop RNAi-based drugs that can be delivered to target cells, offering a precise and customizable approach to gene therapy. Challenges in harnessing RNAi for therapeutic purposes include effective delivery of RNA molecules to target tissues, off-target effects, and potential immune responses. Researchers are actively exploring innovative delivery systems, such as lipid nanoparticles and viral vectors, to overcome these obstacles.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy